Intranasal Vasopressin Treatment in Children With Autism
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2019
Price : $35 *
At a glance
- Drugs Vasopressin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2018 Status changed from not yet recruiting to recruiting.
- 20 Sep 2017 Planned initiation date changed from 1 Jul 2017 to 1 Oct 2017.